- ###01_TYPOLINK_CONTACT###
July 12, 2012, Parsippany, NJ, USA – The STA® – Rivaroxaban Calibrator and Controls are highly specific, automation-ready products for determining the rivaroxaban concentration in plasma when used in conjunction with the STA® -...
Read moreJune 29, 2012, Parsippany, NJ, USA – Diagnostica Stago, Inc. announces products to suit a variety of clinical research needs for factor VII (FVII). Factor VII is a zymogen that upon activation to its active form, factor VIIa...
Read moreApril 10, 2012, Parsippany, NJ, USA – Diagnostica Stago, Inc. (DSI) has joined AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) dedicated to addressing the policy and regulatory issues facing in...
Read moreJanuary 4, 2012, Parsippany, NJ, USA – Diagnostica Stago announces three new products to suit a variety of clinical research needs for procoagulant and total microparticle detection. Microparticles are tissue factor-bearing...
Read more
July 1, 2011, Parsippany, NJ, USA – Diagnostica Stago, Inc. (DSI), recently finalized the acquisition of Thrombinoscope BV, based in Maastricht, The Netherlands. This company, researches, develops and markets thrombin generation...
Read more